Perceptive Advisors LLC

Perceptive Advisors LLC reported 108 holdings worth US$5.74B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Perceptive Advisors LLC reported 108 holdings worth US$5.74B as of Sep 30, 2026. Largest: Praxis Precision Medicines, Inc., Amylyx Pharmaceuticals, Inc. and Spyre Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
108
Value as reported
US$5.74B

The filing in full

CompanySharesValue as reported% of portfolio
Praxis Precision Medicines, Inc.2.02MUS$590M10.3%
Amylyx Pharmaceuticals, Inc.10.6MUS$308M5.4%
Spyre Therapeutics, Inc.3.28MUS$292M5.1%
Celcuity Inc.3.18MUS$253M4.4%
Rhythm Pharmaceuticals, Inc.2.53MUS$241M4.2%
Roivant Sciences Ltd.6.51MUS$238M4.1%
Relay Therapeutics, Inc.12.7MUS$230M4.0%
Travere Therapeutics, Inc.3.54MUS$209M3.6%
Freenome, Inc.12.6MUS$199M3.5%
Edgewise Therapeutics, Inc.4.14MUS$168M2.9%
Inhibrx Biosciences, Inc.1.29MUS$129M2.3%
Nurix Therapeutics, Inc.5.37MUS$127M2.2%
Kardigan, Inc.8.2MUS$121M2.1%
MeiraGTx Holdings plc10.8MUS$119M2.1%
Protagonist Therapeutics, Inc.837KUS$118M2.1%
Zymeworks Inc.3.55MUS$93.9M1.6%
Oruka Therapeutics, Inc.1.07MUS$89.3M1.6%
Revolution Medicines, Inc.433KUS$88.9M1.5%
Solid Biosciences Inc.11.9MUS$86.1M1.5%
BioCryst Pharmaceuticals, Inc.10.3MUS$85.8M1.5%
Avalyn Pharma Inc.2.68MUS$76.2M1.3%
Tango Therapeutics, Inc.2.69MUS$67.2M1.2%
Waters Corporation135KUS$59.3M1.0%
Repligen Corporation272KUS$52.4M0.91%
Artivion, Inc.2.11MUS$48.2M0.84%
Alto Neuroscience, Inc.1.76MUS$45M0.78%
Opus Genetics, Inc.9MUS$43.6M0.76%
Lakefront Biotherapeutics1.24MUS$36.8M0.64%
Abbott Laboratories345KUS$34.1M0.59%
BlossomHill Therapeutics, Inc.1.81MUS$33.8M0.59%
Orchestra BioMed Holdings, Inc.5.04MUS$31.3M0.55%
Corvus Pharmaceuticals, Inc.2.51MUS$28.9M0.50%
Anteris Technologies Global Corp.3.43MUS$26.6M0.46%
Adlai Nortye Group Ltd.1.66MUS$26.6M0.46%
MiniMed Group, Inc.1.32MUS$25.7M0.45%
CytomX Therapeutics, Inc.9.27MUS$25.2M0.44%
Rapport Therapeutics, Inc.724KUS$24.3M0.42%
Septerna, Inc.567KUS$22.2M0.39%
X4 Pharmaceuticals, Inc.7.35MUS$21.3M0.37%
Enliven Therapeutics, Inc.463KUS$21.2M0.37%
SAB Biotherapeutics, Inc.6.63MUS$21M0.37%
Dyne Therapeutics, Inc.1.27MUS$20.4M0.36%
Evolus, Inc. Common Stock2.46MUS$19.7M0.34%
Immunovant, Inc.519KUS$17.5M0.31%
Scribe Therapeutics Inc.920KUS$16.9M0.30%
Nautilus Biotechnology, Inc.11.6MUS$16.4M0.29%
Sutro Biopharma, Inc.971KUS$15.6M0.27%
Surrozen, Inc.440KUS$14.1M0.25%
GRAIL, Inc.96,911US$13.6M0.24%
DBV Technologies SA1.14MUS$13.4M0.23%
Danaher Corporation60,000US$13.3M0.23%
iRhythm Holdings, Inc.114KUS$12.9M0.23%
Guardant Health, Inc.70,000US$12.5M0.22%
Invivyd, Inc.13.8MUS$12M0.21%
Adaptive Biotechnologies Corporation412KUS$11.9M0.21%
Veradermics, Incorporated97,000US$11.8M0.20%
Axogen, Inc.280KUS$11.7M0.20%
Palisade Bio, Inc.8.43MUS$11.4M0.20%
Crescent Biopharma, Inc.707KUS$10.3M0.18%
Beta Bionics, Inc.538KUS$10.2M0.18%
Seaport Therapeutics, Inc.500KUS$10.1M0.18%
Mirum Pharmaceuticals, Inc.115KUS$9.86M0.17%
Xeris Biopharma Holdings, Inc.934KUS$8.93M0.16%
Research Alliance Corporation IV700KUS$8.29M0.14%
Capricor Therapeutics, Inc.850KUS$8.05M0.14%
Viridian Therapeutics, Inc.381KUS$7.85M0.14%
Abivax SA74,000US$7.33M0.13%
BillionToOne, Inc.65,209US$6.94M0.12%
AgomAb Therapeutics NV600KUS$6.66M0.12%
LeonaBio, Inc.1.86MUS$6.64M0.12%
Biogen Inc.28,030US$6.33M0.11%
ADARx Pharmaceuticals, Inc.300KUS$5.98M0.10%
Nuvectis Pharma, Inc.240KUS$5.07M0.09%
Olema Pharmaceuticals, Inc.575KUS$4.97M0.09%
UnitedHealth Group Incorporated10,000US$3.67M0.06%
Mobia Medical, Inc.344KUS$3.25M0.06%
Outset Medical, Inc.833KUS$2.5M0.04%
CeriBell, Inc.98,779US$2.41M0.04%
Edesa Biotech, Inc.563KUS$2.37M0.04%
Braveheart Bio, Inc.115KUS$2.32M0.04%
Outlook Therapeutics, Inc.3.14MUS$1.8M0.03%
Adagio Medical Holdings, Inc9.88MUS$1.51M0.03%
ADMA Biologics Inc114KUS$1.14M0.02%
Kiora Pharmaceuticals, Inc.438KUS$1.12M0.02%
Medline Inc.28,000US$972K0.02%
Exagen Inc.115KUS$934K0.02%
Connect Biopharma Holdings Limited793KUS$872K0.02%
Sagimet Biosciences Inc. - Series A67,674US$669K0.01%
iShares Bitcoin Trust ETF12,000US$568K<0.01%
Ensysce Biosciences, Inc.86,666US$36,036<0.01%
Research Alliance Corporation III0US$00.00%
Sionna Therapeutics, Inc.0US$00.00%
Tenax Therapeutics, Inc.0US$00.00%
Twist Bioscience Corporation0US$00.00%
Apogee Therapeutics, Inc.0US$00.00%
Avalo Therapeutics, Inc.0US$00.00%
Axsome Therapeutics, Inc.0US$00.00%
Biodesix, Inc.0US$00.00%
Boston Scientific Corporation0US$00.00%
Charles River Laboratories International, Inc.0US$00.00%

Every holding of Perceptive Advisors LLC

Source

Download original · View original at SEC

Related